- FAQs – On DPCO: Drugs (Prices Control) Order, 2013 - April 20, 2021
- FAQs – on Blood Pressure Monitoring Devices - March 23, 2021
- FAQs – on Alcohol(in Pharma Industry) - March 19, 2021
Last Updated on July 24, 2021 by The Health Master
FAQs – on Notification: Marketer of drugs
Ministry of Health and Family Welfare has amended the Drugs and Cosmetics Rules, 1945 vide notification No. G.S.R. 101(E) dated 11-02-2020 regarding the Marketer. These rules may be called the Drugs and Cosmetics (Amendment) Rules, 2020.
To download the notification, click here
Q1. Weather Medical Representative is responsible for the quality of dugs of the manufacturer or marketer as per above notification.
Ans: No, as per notification Medical Representative is not responsible for the quality of drugs.
Q2. Shall Marketer be responsible for the quality of drugs ?
Ans: Marketer shall be responsible for the quality of drugs as well as other regulatory compliances along with the manufacturer.
Q3. From which date this notification shall come into force ?
Ans: This notification shall come into force on the 1st day of March, 2021.
Q4. Whether an agreement is required between the Manufacturer and Marketer ?
Ans: Yes, an agreement is required between the manufacture and the marketer.
Q5. Can marketer label or affix his name and address on the labels of the drug ?
Ans: Yes, Marketer can label or affix his name and address on the labels of the drug.